Abnormal prostate development in C3(1)-bcl-2 transgenic mice

Xuejun Zhang, Min Wei Chen, Albert Ng, Po Ying Ng, Chung Lee, Mark Rubin, Carl A. Olsson, Ralph Buttyan*

*Corresponding author for this work

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

BACKGROUND. Recent hypotheses to explain the etiology of abnormal growth associated with prostate disease have invoked perturbations in the rate of apoptosis as an important contributor to the onset and progression of these diseases. For this reason, the apoptosis suppressing oncoprotein bcl-2 has come under scrutiny with regards to its role in prostate diseases. In order to evaluate the role of bcl-2 in human prostate disease and to develop an animal model to test anti-bcl-2 therapies, we generated transgenic mice in which bcl-2 expression is targeted to the mouse prostate gland. METHODS. Mouse embryos were microinjected with recombinant DNA constructed by fusing a modified rat C3(1) promotor element to cDNA encoding human bcl-2. Presence of the C3(1)-bcl-2 transgene in progeny was identified by Southern blot and polymerase chain reaction (PCR) analysis. RNase protection assays were used to analyze RNA from 15 organs of these mice. Western blot assays and immunohistochemical staining were used to confirm the tissue-specific protein expression of human bcl-2 and its cellular localization. RESULTS. Three lines of C3(1)-bcl-2 transgenic mice were established. Founder mice carried 2-20 copies of the transgene. Expression of human bcl-2 from the transgene was limited to the prostate gland and testis of males as well as the uterus of females. In the prostate gland, human bcl-2 protein was found only in prostatic epithelial cells. Microscopic analysis of prostate glands from individual males (three lines) showed that these glands were often abnormal, with increased accumulation of cells in the prostatic stroma as well as the epithelium. CONCLUSIONS. These transgenic mice appear to provide a novel animal model for studying neoplastic development of the prostate, with particular emphasis on the bcl-2 protein and the role of apoptosis regulation in such development.

Original languageEnglish (US)
Pages (from-to)16-26
Number of pages11
JournalProstate
Volume32
Issue number1
DOIs
StatePublished - Jun 15 1997

Keywords

  • Apoptosis
  • Prostate gland
  • Prostate-steroid-binding protein
  • Transgenic mice
  • bcl-2

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Abnormal prostate development in C3(1)-bcl-2 transgenic mice'. Together they form a unique fingerprint.

  • Cite this

    Zhang, X., Chen, M. W., Ng, A., Ng, P. Y., Lee, C., Rubin, M., Olsson, C. A., & Buttyan, R. (1997). Abnormal prostate development in C3(1)-bcl-2 transgenic mice. Prostate, 32(1), 16-26. https://doi.org/10.1002/(SICI)1097-0045(19970615)32:1<16::AID-PROS3>3.0.CO;2-A